[Drug surveillance. Monitoring the collateral effects of drugs in the post-marketing phase: cimetidine. I].
作者信息
Mariani L, Minora T
出版信息
Clin Ter. 1984 Apr 15;109(1):3-17.
PMID:6233077
Abstract
摘要
相似文献
1
[Drug surveillance. Monitoring the collateral effects of drugs in the post-marketing phase: cimetidine. I].[药物监测。上市后阶段药物副作用监测：西咪替丁。I]
Clin Ter. 1984 Apr 15;109(1):3-17.
2
[Side effects of cimetidine: a cooperative work of "Centres de pharmaco-vigilance hospitalière" (author's transl)].西咪替丁的副作用：“医院药物警戒中心”的合作研究（作者译）
Therapie. 1980 Jan-Feb;35(1):83-112.
3
[Drug surveillance. Monitoring the side-effects of drugs in the post-marketing phase: cimetidine. II].[药物监测。上市后阶段药物副作用的监测：西咪替丁。II]
Clin Ter. 1984 Apr 30;109(2):109-25.
4
[On the toxic side-effects of antitubercular agents].[论抗结核药物的毒副作用]
Clin Ter. 1972 Apr 30;61(2):143-68.
5
Cimetidine: II. Adverse reactions and patterns of use.西咪替丁：II. 不良反应及使用模式
Ann Intern Med. 1982 Nov;97(5):728-34. doi: 10.7326/0003-4819-97-5-728.
6
7
A critical review of the literature on carbon disulfide toxicity.
Crit Rev Toxicol. 1983;11(3):169-278. doi: 10.3109/10408448309128255.
8
Late toxic effects of cytotoxic drugs.细胞毒性药物的迟发毒性作用。
Minn Med. 1974 Jan;57(1):19-21 passim.
9
Postmarketing surveillance of the safety of cimetidine: mortality during second, third, and fourth years of follow up.西咪替丁安全性的上市后监测：随访第二、三、四年期间的死亡率
Br Med J (Clin Res Ed). 1985 Oct 19;291(6502):1084-8. doi: 10.1136/bmj.291.6502.1084.
10
[Undesired effects of cimetidine: review of the literature].
Clin Ter. 1981 Jan 15;96(1):81-91.
Zotero 插件